Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of Comparison of Combination Therapy of Gliclazide MR and Basal Insulin With Pre-mix Insulin Monotherapy for the Patients With Type 2 Diabetes Mellitus

NCT00736515 is registered in ClinicalTrials.gov with Servier (Tianjin) Pharmaceutical Co. LTD. as lead sponsor.

NCT NCT00736515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00736515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of Comparison of Combination Therapy of Gliclazide MR and Basal Insulin With Pre-mix Insulin Monotherapy for the Patients With Type 2 Diabetes Mellitus
Lead sponsor
Servier (Tianjin) Pharmaceutical Co. LTD.
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2008
Completion date
August 31, 2011
Enrollment
160 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes